Hematopoietic stem cell transplantation (HSCT) exposes a patient's kidneys to a unique
combination of challenges, including high-dose radiation, anemia, chemotherapeutic …

Background Various glomerular pathologies have been reported in patients who have
undergone haematopoietic stem cell transplantation (HSCT), but the data on clinico …

Allogeneic hemopoietic stem cell transplantation (allo‐HSCT) poses a significant challenge
to renal function due to multiple drug‐and complication‐related renal toxicity. In this single …

Acute kidney injury (AKI) increases early mortality in allogeneic hematopoietic cell transplant
(allo-HCT) recipients and may accelerate chronic kidney disease (CKD) development. We …

Acute kidney injury (AKI) is highly prevalent whether the patients undergo myeloablative or
non-myeloablative hematopoietic cell transplantation (HCT); however, the pathogenesis and …

After transplantation of solid organs or hematopoietic stem cells, a significant acute
decrease in renal function occurs in the majority of patients. Depending on the degree of …

Acute renal failure after myeloablative hematopoietic cell transplant: Incidence and risk
factors. Background Survival after myeloablative therapy followed by hematopoietic cell …

Results Incidence of AKI by day 100 was 64%. Exposure to tacrolimus and other
nephrotoxins conferred a higher risk of AKI, but tacrolimus levels were not associated with …

Patients with the recovery of kidney function after an episode of acute kidney injury (AKI)
have better outcomes compared to those without recovery. The current systematic review is …

Background. Chronic kidney disease (CKD) seems to be common in long-term survivors of
haematopoietic cell transplantation (HCT). However, the range of its frequency is very wide …